Selenium supplementation and insulin resistance in a randomized, clinical trial

OBJECTIVE: While controversial, observational and randomized clinical trial data implicate the micronutrient selenium (Se) in the development of type 2 diabetes (T2D). The aim of this study was to test the hypothesis that Se supplementation adversely affects pancreatic β-cell function and insulin se...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobs, Elizabeth Theresa, Lance, Peter, Mandarino, Lawrence J, Ellis, Nathan A, Chow, H-H Sherry, Foote, Janet, Martinez, Jessica A, Hsu, Chiu-Hsieh Paul, Batai, Ken, Saboda, Kathylynn, Thompson, Patricia A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Epidemiology/Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398811/
https://www.ncbi.nlm.nih.gov/pubmed/30899530
http://dx.doi.org/10.1136/bmjdrc-2018-000613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398811/
https://www.ncbi.nlm.nih.gov/pubmed/30899530
http://dx.doi.org/10.1136/bmjdrc-2018-000613

Ejemplares similares